Mv Management Xi, L.L.C is an investment fund managing more than $60.1 billion ran by Venky Ganesan. There are currently 3 companies in Ganesan’s portfolio. The largest investments include Rover Group Inc and Recursion Pharmaceuticals In, together worth $60.1 billion.
As of 7th November 2023, Mv Management Xi, L.L.C’s top holding is 8,638,513 shares of Rover Group Inc currently worth over $54.1 billion and making up 90.0% of the portfolio value.
In addition, the fund holds 788,762 shares of Recursion Pharmaceuticals In worth $6.03 billion.
The third-largest holding is Angi Inc worth $3.76 million.
Currently, Mv Management Xi, L.L.C's portfolio is worth at least $60.1 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Mv Management Xi, L.L.C office and employees reside in Menlo Park, California. According to the last 13-F report filed with the SEC, Venky Ganesan serves as the Managing Member of General Partner at Mv Management Xi, L.L.C.
Venky Ganesan disclosed a decreased stake in Rover Group Inc by 0.3%.
This leaves the value of the investment at $54.1 billion and 8,638,513 shares.
The two most similar investment funds to Mv Management Xi, L.L.C are Offit Capital Advisors and Dynamo Administracao De Recursos Ltda. They manage $60.1 billion and $60.2 billion respectively.
Mv Management Xi, L.L.C’s portfolio is diversified across 2 sectors.
Currently, their heaviest sector is Technology — making up approximately 0.1% of
the total portfolio value.
The fund focuses on investments in the United States as
33.3% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
approximately 0.1% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $1.01 billion.
These positions were updated on November 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Rover Group Inc |
25.00%
8,638,513
|
$54,077,091,000 | 89.96% |
| Recursion Pharmaceuticals In |
60.00%
788,762
|
$6,034,029,000 | 10.04% |
| Angi Inc |
No change
1,898
|
$3,758,000 | 0.01% |
| No transactions found | |||
| Showing first 500 out of 3 holdings | |||